Here we go again.

After spending months sorting through a multitude of Medicare drug-benefit options for 2006, seniors have the chance to undergo the dizzying experience all over again. That is because this week insurers begin marketing their 2007 drug plans before the six-week enrollment season kicks off Nov. 15.

The good news is that most seniors who are satisfied with the plan they are enrolled in don't have to do anything. Some analysts had predicted a shakeout after dozens of providers rushed into the new drug-benefit market last year, but few companies are actually canceling plans.

Still, the drug-benefit landscape is changing enough that even enrollees who are content may want to review how their plan stacks up against new offerings. Beneficiaries in most states will have 50 to 60 offerings to choose from, at least 10 more than in 2006. Some plans are adding benefits -- including eliminating co-payments for generic drugs. But at least one, Humana Inc., is rolling back one of the richest benefits on the market: coverage for brand-name drugs during a phase known as the "doughnut hole" that requires many beneficiaries to pay the full cost of drugs after reaching a certain cost threshold.

Advertise with us

For the most basic plans, prices are converging, though there are still some big differences. Last year companies announced drug-benefit premiums without knowing how the competitive landscape would shape up. Consequently, prices ranged widely, from as little as $1.87 a month to more than $35 for a basic plan. Now for 2007, Humana still sells the cheapest plan in 38 states, but premiums for its basic option have climbed to between $10.20 and $18.20. Meanwhile, Cigna Corp. and Aetna Inc., whose prices were some of the highest, have lowered theirs by as much as 30 percent. (Cigna's basic option ranges from $17 to $31; Aetna's costs $24.80 to $30.80.)

To compare the 2007 plan offering, seniors can also tap a number of new or enhanced online tools. Later this month, Medicare's Plan Finder at www.medicare.gov and www.mymedicare.gov will let beneficiaries compare out-of-pocket costs and benefits for the 2007 plans in their area. Seniors can see what plans are available in each state at www.medicare.gov/medicarereform/local-plans-2007.asp. A new Web site, www.partdoptimizer.com, is run by DestinationRx, which provided software for Medicare's comparison tools. It provides tips on avoiding the doughnut hole and compares how much seniors would save by switching to alternative medicines within their current plan. The site currently has data for 2006 plans but will be able to crunch 2007 information after the enrollment period has ended Dec. 31.

Who should consider switching? Prime candidates are those who picked plans for this year that provided coverage of the so-called doughnut hole, or who fell into that gap and now want coverage for it. The doughnut hole refers to a portion of drug spending that the government-subsidized plans don't have to cover. Seniors get coverage for up to $2,400 in spending in 2007. The federal subsidies then stop until the patient reaches $3,850 in out-of-pocket expenses. After that, the coverage kicks in again and covers 95 percent of drug purchases for the rest of the year. For a higher premium, some plans offer to cover drug expenses through the gap.

It is these higher-end plans that are seeing some of the biggest changes in 2007. For starters, there are many more available. Just 15 percent of plans this year provided coverage of the doughnut hole, according to Avalere Health LLC, a health-care consulting firm in Washington, D.C. Next year 29 percent of them will.

This year in New Jersey, for instance, Humana sold one of these more-comprehensive plans for a $48.50 monthly premium, while Cigna's cost a bit more -- $51.36. In 2007, the Humana premium will jump 46 percent to $71.20. Cigna, though, which signed up fewer beneficiaries than it had hoped for 2006, has dropped its price, to $38.20.

Advertise with us

What's more, Humana is joining the majority of its rivals in providing coverage for only generics during the doughnut hole. This year, it was the only major insurer to provide coverage of many brand-name drugs through the gap. But as a result, it says it attracted more than its share of sicker enrollees with higher-than-average medication costs -- and lost money on the higher-end plan. "We'd assumed that other national plans would offer brand coverage through the gap, but none did," says Scott Latimer, Humana's market president for central and northern Florida.

Of Humana's 3.5 million drug-plan enrollees, about 12 percent, or 420,000 people, are currently in its most-comprehensive plan and will no longer have their brand-name drugs covered through the doughnut hole, Humana says.

On the whole, though, 5 percent of all plans will offer both brand-name and generic drug coverage through the gap, an increase from this year, according to Avalere. In Michigan, Coventry Health Care Inc. is one of just a few companies that is raising the price of its most comprehensive plan, from $42.40 to $48. In doing so, it is adding generics and brand-name drugs to its gap coverage. But seniors should check if such benefit improvements apply to their drugs. Coventry says only some preferred brand drugs in its first tier of coverage are included alongside the generics.

"You have to read the fine print," says John Gorman, president and chief executive of Gorman Health Group, a Washington health-care consulting company.

In another shift, many plans are making changes that will reduce the chances that consumers will even reach the $2,400 level where the coverage gap starts. By eliminating co-pays for generic drugs in some plans, for instance, insurers are making such treatments essentially free to patients (at least until they reach the coverage gap). Aetna is dropping co-pays for generics in many of its plans, while Cigna says it is eliminating generic co-pays in all of its most basic drug plans.

Advertise with us

Peter Ashkenaz, a spokesman for the federal Centers for Medicare and Medicaid Services, says every beneficiary will be notified if there is any change in their plan.

Even if beneficiaries want to stay in their current plan, they should still check that the drugs they take are remaining on their plan's formulary and on the same co-pay "tier" as before. A move from the lowest to a higher tier of co-payments for a drug can translate into a rise in co-pay to $40 a month from $5.

There may be a huge market of potential shoppers. Only 20 percent of 3,400 beneficiaries surveyed last month by J.D. Power & Associates said they would definitely stay with the plan they had. About two million Americans will turn 65 in 2007 and also will be eligible. At least another four million, including three million low-income beneficiaries not subject to penalties for missing the deadline earlier this year, have yet to enroll.

Still, unless another plan has the potential to save a beneficiary substantial money each month, some Medicare watchers say that many may decide to stay put. Few predict that any player will break the lock that the country's three biggest plans -- UnitedHealth Group Inc., Humana and WellPoint Inc. -- have on the majority of the market.

"People went through so much trauma picking a plan the first year," says Robert Laszewski, a Washington-based health-care consultant. "They're not going to open this up all over again just to save a few bucks."

Advertise with us

New Landscape

Some changes for next year's Medicare drug-benefit plans.

More offerings. Beneficiaries in most states will have 50 to 60 plans to choose from.

More plans with coverage during the "doughnut hole," though mostly for generics.

The median premium fell to $33 from $36, but some companies did raise premiums.

Advertise with us

Fewer low-cost plans available. In 2007, 5.5 percent of plans have premiums lower than $20, down from 6.3 percent in 2006.

Source: Avalere Health